Details for New Drug Application (NDA): 206720
✉ Email this page to a colleague
The generic ingredient in OLMESARTAN MEDOXOMIL is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are fifty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.
Summary for 206720
Tradename: | OLMESARTAN MEDOXOMIL |
Applicant: | Prinston Inc |
Ingredient: | olmesartan medoxomil |
Patents: | 0 |
Pharmacology for NDA: 206720
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 206720
Suppliers and Packaging for NDA: 206720
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 206720 | ANDA | Solco Healthcare US, LLC. | 43547-299 | 43547-299-03 | 30 TABLET in 1 BOTTLE (43547-299-03) |
OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 206720 | ANDA | Solco Healthcare US, LLC. | 43547-299 | 43547-299-09 | 90 TABLET in 1 BOTTLE (43547-299-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Dec 2, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Dec 2, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Dec 2, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription